USD 0.35
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | 67.33 Thousand USD | -74.92% |
2023 | 508 Thousand USD | -34.03% |
2022 | 770 Thousand USD | -54.17% |
2021 | 1.68 Million USD | 46.72% |
2020 | 1.14 Million USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 101 Thousand USD | 84.92% |
2014 | 54.61 Thousand USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | -100.0% |
2010 | 350 Thousand USD | 0.0% |
2009 | - USD | -100.0% |
2008 | 606 Thousand USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | -100.0% |
2004 | 16 Thousand USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 1.15 Million USD | 0.06% |
2024 Q1 | 430 Thousand USD | -4.82% |
2024 FY | 67.33 Thousand USD | -86.74% |
2024 Q3 | 232.94 Thousand USD | -8.9% |
2024 Q4 | 67.33 Thousand USD | -71.09% |
2023 Q3 | 578 Thousand USD | -15.79% |
2023 Q1 | 678 Thousand USD | -11.95% |
2023 FY | 508 Thousand USD | -34.03% |
2023 Q4 | 508 Thousand USD | -12.11% |
2023 Q2 | 686.35 Thousand USD | 1.23% |
2022 Q1 | 1.59 Million USD | -4.94% |
2022 Q2 | 981 Thousand USD | -38.57% |
2022 Q3 | 860 Thousand USD | -12.33% |
2022 Q4 | 770 Thousand USD | -10.47% |
2022 FY | 770 Thousand USD | -54.17% |
2021 FY | 1.68 Million USD | 46.72% |
2021 Q2 | 1.83 Million USD | 4.33% |
2021 Q1 | 1.75 Million USD | 53.36% |
2021 Q4 | 1.68 Million USD | 45.2% |
2021 Q3 | 1.15 Million USD | -36.84% |
2020 Q4 | 1.14 Million USD | -5.84% |
2020 Q2 | 1.01 Million USD | -5.31% |
2020 Q3 | 1.21 Million USD | 19.57% |
2020 FY | 1.14 Million USD | 0.0% |
2020 Q1 | 1.07 Million USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2016 Q4 | - USD | -100.0% |
2016 FY | - USD | -100.0% |
2016 Q1 | 93 Thousand USD | -7.92% |
2016 Q2 | 86 Thousand USD | -7.53% |
2016 Q3 | 78 Thousand USD | -9.3% |
2015 Q4 | 101 Thousand USD | -7.34% |
2015 FY | 101 Thousand USD | 84.92% |
2015 Q2 | 145 Thousand USD | -12.12% |
2015 Q1 | 165 Thousand USD | 202.09% |
2015 Q3 | 109 Thousand USD | -24.83% |
2014 Q1 | 122 Thousand USD | 0.0% |
2014 FY | 54.61 Thousand USD | 0.0% |
2014 Q4 | 54.61 Thousand USD | -74.11% |
2014 Q3 | 211 Thousand USD | 137.08% |
2014 Q2 | 89 Thousand USD | -27.05% |
2013 Q4 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | -100.0% |
2011 FY | - USD | -100.0% |
2011 Q2 | 581.26 Thousand USD | 0.0% |
2011 Q1 | - USD | -100.0% |
2010 Q1 | - USD | 0.0% |
2010 Q3 | 275 Thousand USD | 22.22% |
2010 FY | 350 Thousand USD | 0.0% |
2010 Q2 | 225 Thousand USD | 0.0% |
2010 Q4 | 350 Thousand USD | 27.27% |
2009 Q2 | 505.03 Thousand USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | -100.0% |
2009 FY | - USD | -100.0% |
2009 Q1 | - USD | -100.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | 606 Thousand USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | 606 Thousand USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2005 FY | - USD | -100.0% |
2005 Q3 | 3923.00 USD | -49.99% |
2005 Q1 | 11.76 Thousand USD | -26.46% |
2005 Q4 | - USD | -100.0% |
2005 Q2 | 7845.00 USD | -33.33% |
2004 Q2 | 23.53 Thousand USD | 0.0% |
2004 FY | 16 Thousand USD | 0.0% |
2004 Q3 | 19.61 Thousand USD | -16.66% |
2004 Q4 | 16 Thousand USD | -18.42% |
2004 Q1 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1997 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Medical Technologies Inc. | - USD | -Infinity% |
Ansell Limited | 705.27 Million USD | 99.99% |
Ansell Limited | 706.6 Million USD | 99.99% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 22.41 Million USD | 99.7% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | - USD | -Infinity% |
Psykey, Inc. | 625 Thousand USD | 89.226% |
ConvaTec Group Plc | 1.22 Billion USD | 99.995% |
ConvaTec Group Plc | 1.22 Billion USD | 99.995% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 382.83 Thousand USD | 82.411% |
LifePoint, Inc. | 151.73 Thousand USD | 55.622% |
Medite Cancer Diagnostics, Inc. | 4.91 Million USD | 98.63% |
Paradigm Medical Industries, Inc. | 615 Thousand USD | 89.051% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | - USD | -Infinity% |
Reflect Scientific, Inc. | 179.96 Thousand USD | 62.583% |
SmileDirectClub, Inc. | 849.37 Million USD | 99.992% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | 99.968% |
SheerVision, Inc. | - USD | -Infinity% |
United Health Products, Inc. | 48.48 Thousand USD | -38.869% |
Vasamed, Inc. | 18.95 Thousand USD | -255.335% |
Wearable Health Solutions, Inc. | 18.46 Thousand USD | -264.609% |
Yubo International Biotech Limited | 390.44 Thousand USD | 82.754% |